Female Sovereignty: Disorienting Feminist Rhetoric in the Italian Far Right
Public Humanities · 2026 · 2
DOI: 10.1017/pub.2026.10157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Humanities, online erschienen am 07.04.2026. Verfasst von Ombretta Frau und 1 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Our article aims to show how right-wing women in positions of power like Italian Prime Minister Giorgia Meloni are able to manipulate feminism to their political advantage. Stemming from our previous study on Meloni’s particular brand of conservative feminism, we analyze the disorienting ability of the right to appropriate and manipulate the traditional language of the left. We are interested in this creation of confusion through rhetorical somersaults on the Italian political stage, specifically how the right appropriates feminist language and themes to further neoliberal economics, neoconservative morals, and a nationalist agenda that is hostile to women, nonwhite people, migrants, and LGBTQIA+ communities. As a case study, we offer an analysis of the ideas of one of Italy’s most prominent gender-critical feminists, Marina Terragni, who challenges assumptions about feminism’s ties to the left. Promoting a strictly binary vision, Terragni highlights the fault lines in the relationship between traditional and progressive feminism.
Zitieren
APA
Frau, O., & Guzzetta, J. (2026). Female Sovereignty: Disorienting Feminist Rhetoric in the Italian Far Right. Public Humanities, 2. https://doi.org/10.1017/pub.2026.10157
Vancouver
Frau O, Guzzetta J. Female Sovereignty: Disorienting Feminist Rhetoric in the Italian Far Right. Public Humanities. 2026;2. doi:10.1017/pub.2026.10157
BibTeX
@article{Frau2026,
author = {Frau, Ombretta and Guzzetta, Juliet},
title = {Female Sovereignty: Disorienting Feminist Rhetoric in the Italian Far Right},
journal = {Public Humanities},
year = {2026},
volume = {2},
doi = {10.1017/pub.2026.10157}
}
EUVIMED